Keum; Gyo Chang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Keum; Gyo Chang.The latest application filed is for "pharmaceutical composition containing stabilized nucleic acid adjuvant".

Company Profile

4.14.14

Keum; Gyo Chang - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Indazole derivatives and pharmaceutical composition for preventing, alleviating or treating cancer containing the same Grant 11,407,745 - Keum , et al. August 9, 2	2022-08-09
Pharmaceutical Composition Containing Stabilized Nucleic Acid Adjuvant App 20220233700 - NAM; Jae Hwan ; et al.	2022-07-28
Novel Compounds Useful As Near-infrared Fluorescent Probes Selectively Binding To Tau Aggregates And Method Of Preparing The Same App 20210255203 - NAM; Ghil Soo ; et al.	2021-08-19
Novel Indazole Derivatives And Pharmaceutical Composition For Preventing, Alleviating Or Treating Cancer Containing The Same App 20200392127 - KEUM; Gyo Chang ; et al.	2020-12-17
Carbazole compound having anti-virus activity Grant 10,421,779 - Keum , et al. Sept	2019-09-24
Zn-DPA complex compounds and siRNA delivery systems containing the same Grant 10,190,120 - Keum , et al. Ja	2019-01-29
Carbazole Compound Having Anti-virus Activity App 20180057527 - KEUM; Gyo Chang ; et al.	2018-03-01
NOVEL Zn-DPA COMPLEX COMPOUNDS AND siRNA DELIVERY SYSTEMS CONTAINING THE SAME App 20180044674 - KEUM; Gyo Chang ; et al.	2018-02-15
Carbazole derivatives acting on 5-HT7 receptor Grant 9,663,464 - Choo , et al. May 30, 2	2017-05-30
Carbazole Derivatives Acting On 5-ht7 Receptor App 20160244408 - CHOO; Hyunah ; et al.	2016-08-25
Oxazolidinone derivatives and composition for preventing or treating hepatitis C containing the same Grant 9,422,274 - Jang , et al. August 23, 2	2016-08-23
Oxazolidinone derivatives and composition for preventing or treating Hepatitis C containing the same App 20150148386 - JANG; Sung Key ; et al.	2015-05-28
Benzoarylureido compounds, and composition for prevention or treatment of neurodegenerative brain disease containing the same Grant 9,012,481 - Hahn , et al. April 21, 2	2015-04-21
6-pyrazolylamido-3-substituted azabicyclo[3.1.0]hexane compounds as calcium channel inhibitors Grant 8,895,602 - Nam , et al. November 25, 2	2014-11-25
Novel 6-pyrazolylamido-3-substituted Azabicyclo[3.1.0]hexane Compounds As Calcium Channel Inhibitors App 20140343295 - NAM; Ghil Soo ; et al.	2014-11-20
Oxazolidinone derivatives containing new bicyclic group, having antibacterial activity, and method for treating pathogenic bacterial infections using the same Grant 8,507,540 - Keum , et al. August 13, 2	2013-08-13
Imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof Grant 8,492,384 - Choi , et al. July 23, 2	2013-07-23
Oxazolidinone Derivatives Containing New Bicyclic Group, Having Antibacterial Activity, And Method For Treating Pathogenic Bacterial Infections Using The Same App 20130012554 - KEUM; Gyo-Chang ; et al.	2013-01-10
Pyrazolylmethylamine compounds as calcium channel modulators and preparation method thereof Grant 8,299,072 - Nam , et al. October 30, 2	2012-10-30
Benzoarylureido Compounds, And Composition For Prevention Or Treatment Of Neurodegenerative Brain Disease Containing The Same App 20110319456 - Hahn; Hoh-Gyu ; et al.	2011-12-29
Novel Pyrazolylmethylamine Compounds As Calcium Channel Modulators And Preparation Method Thereof App 20100094006 - NAM; Ghilsoo ; et al.	2010-04-15
Novel Isoindolinone Derivatives Having Inhibitory Activity Against T-type Calcium Channel And Method For Preparation Thereof App 20100004286 - CHO; Yong Seo ; et al.	2010-01-07
Novel Imidazolylalkylcarbonyl Derivatives As Calcium Channel Modulators And Preparation Method Thereof App 20090325979 - CHOI; Kyung Il ; et al.	2009-12-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.